Bolt Biotherapeutics, Inc. (BOLT) has a market capitalization of $8.95M and trades at $4.66. The 52-week range is 3.91-9.24.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.3, Earnings Per Share (EPS) of $-17.85, annual revenue of $7.7M.
The stock has a beta of 0.86, operates in the Healthcare sector.
